Related Experiment Video
Updated: Aug 5, 2025

Monitoring eIF4F Assembly by Measuring eIF4E-eIF4G Interaction in Live Cells
Published on: May 1, 2020
5'-tiRNA-Gln inhibits hepatocellular carcinoma progression by repressing translation through the interaction with
Chengdong Wu1,2,3,4,5,6, Dekai Liu1,2,3,4,5,6, Lufei Zhang1,2,3,4,5,6
1Department of Hepatobiliary and Pancreatic Surgery, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310009, China.
Abstract:
tRNA-derived small RNAs (tsRNAs) are novel non-coding RNAs that are involved in the occurrence and progression of diverse diseases. However, their exact presence and function in hepatocellular carcinoma (HCC) remain unclear. Here, differentially expressed tsRNAs in HCC were profiled. A novel tsRNA, tRNAGln-TTG derived 5'-tiRNA-Gln, is significantly downregulated, and its expression level is correlated with progression in patients. In HCC cells, 5'-tiRNA-Gln overexpression impaired the proliferation, migration, and invasion in vitro and in vivo, while 5'-tiRNA-Gln knockdown yielded opposite results. 5'-tiRNA-Gln exerted its function by binding eukaryotic initiation factor 4A-I (EIF4A1), which unwinds complex RNA secondary structures during translation initiation, causing the partial inhibition of translation. The suppressed downregulated proteins include ARAF, MEK1/2 and STAT3, causing the impaired signaling pathway related to HCC progression. Furthermore, based on the construction of a mutant 5'-tiRNA-Gln, the sequence of forming intramolecular G-quadruplex structure is crucial for 5'-tiRNA-Gln to strongly bind EIF4A1 and repress translation. Clinically, 5'-tiRNA-Gln expression level is negatively correlated with ARAF, MEK1/2, and STAT3 in HCC tissues. Collectively, these findings reveal that 5'-tiRJNA-Gln interacts with EIF4A1 to reduce related mRNA binding through the intramolecular G-quadruplex structure, and this process partially inhibits translation and HCC progression.
Insights
A novel tRNA-derived small RNA (tsRNA), 5'-tiRNA-Gln, is downregulated in hepatocellular carcinoma (HCC). This tsRNA inhibits HCC progression by binding EIF4A1, partially blocking translation and impacting key signaling pathways.
Area of Science:
- Molecular Biology
- Oncology
- RNA Biology
Background:
- tRNA-derived small RNAs (tsRNAs) are emerging non-coding RNAs implicated in various diseases.
- The specific role of tsRNAs in hepatocellular carcinoma (HCC) pathogenesis remains largely undefined.
Purpose of the Study:
- To investigate the expression and function of tsRNAs in HCC.
- To identify novel tsRNAs that regulate HCC progression.
Main Methods:
- Differential expression profiling of tsRNAs in HCC tissues.
- In vitro and in vivo functional assays (overexpression and knockdown) of 5 -tiRNA-Gln.
- RNA-protein binding assays and mechanistic studies involving EIF4A1 and G-quadruplex structures.
- Correlation analysis of tsRNA expression with protein levels in HCC tissues.
Main Results:
- A novel tsRNA, 5 -tiRNA-Gln, derived from tRNA Gln-TTG, was found to be significantly downregulated in HCC.
- Overexpression of 5 -tiRNA-Gln suppressed HCC cell proliferation, migration, and invasion, while knockdown enhanced these processes.
- 5 -tiRNA-Gln binds to eukaryotic initiation factor 4A-I (EIF4A1), partially inhibiting translation initiation and downregulating proteins like ARAF, MEK1/2, and STAT3.
- The G-quadruplex structure within 5 -tiRNA-Gln is critical for its interaction with EIF4A1 and subsequent inhibition of HCC progression.
Conclusions:
- 5 -tiRNA-Gln acts as a tumor suppressor in HCC by interacting with EIF4A1 via its G-quadruplex structure.
- This interaction partially inhibits translation, affecting signaling pathways crucial for HCC progression.
- 5 -tiRNA-Gln represents a potential biomarker and therapeutic target for hepatocellular carcinoma.
Related Concept Videos
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Initiation of Translation
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
Leaky Scanning
Improving Translational Accuracy
MicroRNAs
Experimental RNAi

